Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Dr. Daniel Koller spoke on the Art of Investment Podcast about the long-term growth drivers underlying the biotech sector and some applications of breakthrough mRNA technology and genome editing.

Biotech investing, mRNA and genome editing

Dr. Daniel Koller spoke on the Art of Investment Podcast about the long-term growth drivers underlying the biotech sector and some applications of breakthrough mRNA technology and genome editing.
03.11.2022 - Daniel Koller

This might also interest you

  • BB Biotech AG

    BB Biotech AG (SIX) (CHF)
    ISIN-No.: CH0038389992YTD: 23.47%Active share: 79.47Anzahl Positionen: 22
    Launch date: 16. November 1993